The performance of companies tied to Sildenafil's history presents a complex investment picture . While the initial boom generated substantial profits , generic copies have significantly impacted revenue. Investing in connected pharmaceutical companies now requires a careful assessment of patent rights , evolving healthcare trends , and the potenti